Published in J Biol Chem on June 20, 2012
Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron (2013) 3.63
The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci (2013) 3.16
TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss. Neuron (2017) 2.03
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A (2013) 1.48
Emerging mechanisms of molecular pathology in ALS. J Clin Invest (2015) 1.32
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics (2015) 1.15
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2014) 1.08
RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci (2012) 1.07
Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci (2014) 1.06
Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J (2013) 1.05
Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci U S A (2013) 1.04
Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations. PLoS One (2013) 0.97
Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative disease. Discov Med (2014) 0.96
Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol (2015) 0.95
XBP1 depletion precedes ubiquitin aggregation and Golgi fragmentation in TDP-43 transgenic rats. J Neurochem (2012) 0.94
The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med (2016) 0.94
TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Hum Mol Genet (2014) 0.94
A fruitful endeavor: modeling ALS in the fruit fly. Brain Res (2014) 0.91
Amyotrophic lateral sclerosis: an update on recent genetic insights. J Neurol (2013) 0.89
The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia. Front Cell Neurosci (2015) 0.86
TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J (2015) 0.86
Rodent Models of Amyotrophic Lateral Sclerosis. Curr Protoc Pharmacol (2015) 0.85
The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43. PLoS One (2013) 0.84
The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio (2013) 0.83
The function of RNA-binding proteins at the synapse: implications for neurodegeneration. Cell Mol Life Sci (2015) 0.83
ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation. Acta Neuropathol Commun (2015) 0.83
Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. PLoS One (2014) 0.82
Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins. PLoS One (2014) 0.80
Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System. Neuron (2016) 0.79
TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways. Nucleic Acids Res (2015) 0.79
Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model. Acta Neuropathol (2016) 0.79
TDP-43/FUS in motor neuron disease: Complexity and challenges. Prog Neurobiol (2016) 0.79
Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol Commun (2015) 0.79
Roles for RNA-binding proteins in development and disease. Brain Res (2016) 0.79
Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate. Brain (2016) 0.78
Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions. J Biomed Sci (2013) 0.78
A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects. PLoS One (2014) 0.78
Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int J Mol Sci (2013) 0.77
TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons. EMBO J (2016) 0.77
Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP. Acta Neuropathol (2016) 0.76
Therapeutic and diagnostic challenges for frontotemporal dementia. Front Aging Neurosci (2014) 0.76
Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment. Neural Regen Res (2013) 0.76
TDP-43-The key to understanding amyotrophic lateral sclerosis. Rare Dis (2014) 0.75
Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43. J Biol Chem (2016) 0.75
PABPN1 suppresses TDP-43 toxicity in ALS disease models. Hum Mol Genet (2015) 0.75
Gene targeting of mouse Tardbp negatively affects Masp2 expression. PLoS One (2014) 0.75
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 18.08
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (2008) 14.09
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun (2006) 10.69
Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci (2006) 6.53
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol (1995) 5.18
Rethinking ALS: the FUS about TDP-43. Cell (2009) 4.71
Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron (1999) 4.68
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A (2009) 4.18
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci (2008) 4.01
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol (2010) 3.92
Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics (2004) 3.51
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A (2010) 3.39
Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron (2001) 3.37
Opinion: What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol (2005) 3.18
TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem (2007) 2.91
Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia (1998) 2.82
TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol (2010) 2.81
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol (2008) 2.76
Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci (2010) 2.60
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest (2011) 2.58
Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett (2009) 2.48
TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis (2010) 2.31
Retrograde regulation of motoneuron differentiation by muscle beta-catenin. Nat Neurosci (2008) 2.07
Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci U S A (2010) 1.92
Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet (2010) 1.81
Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med (2010) 1.78
TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol (2007) 1.73
Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb. Neuron (2006) 1.71
TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol Med (2008) 1.70
TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol (2007) 1.64
Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol (2006) 1.61
Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry (2005) 1.55
Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis (2010) 1.51
Anatomy of medial gastrocnemius and soleus motor nuclei in cat spinal cord. J Neurophysiol (1977) 1.51
A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J Biol Chem (2011) 1.48
The molecular links between TDP-43 dysfunction and neurodegeneration. Adv Genet (2009) 1.46
The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS One (2010) 1.32
Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc Natl Acad Sci U S A (2009) 1.31
A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport. J Biol Chem (2011) 1.27
Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci (2009) 1.26
Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 1.18
Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve (1997) 1.16
Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem (2011) 1.10
Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev (2009) 1.07
Lateral motor column axons execute a ternary trajectory choice between limb and body tissues. Neural Dev (2007) 1.05
Axonal regeneration and neuronal function are preserved in motor neurons lacking ß-actin in vivo. PLoS One (2011) 1.01
Neuronal function and dysfunction of Drosophila dTDP. PLoS One (2011) 0.96
Clinical limits of amyotrophic lateral sclerosis. Adv Neurol (1982) 0.96
Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis. Brain Res Bull (1993) 0.95
The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler (2010) 0.94
Localization of TrkC to Schwann cells and effects of neurotrophin-3 signaling at neuromuscular synapses. J Comp Neurol (2007) 0.88
Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathol (2005) 0.86
Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc Natl Acad Sci U S A (2000) 0.86
Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. Pathol Biol (Paris) (1996) 0.86
A method comparison in monitoring disease progression of G93A mouse model of ALS. Amyotroph Lateral Scler (2007) 0.85
Thoracic radicular symptoms in amyotrophic lateral sclerosis. J Neurol Sci (1995) 0.76
Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics (2004) 3.51
TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem (2007) 2.91
TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis (2010) 2.31
Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci U S A (2002) 1.99
TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem (2008) 1.98
Rate of evolution in brain-expressed genes in humans and other primates. PLoS Biol (2007) 1.87
TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol Med (2008) 1.70
Rapidly evolving genes in human. I. The glycophorins and their possible role in evading malaria parasites. Mol Biol Evol (2003) 1.35
Adaptive patterns of movement during arm elevation test in patients with shoulder impingement syndrome. J Orthop Res (2010) 1.34
Epigenetic regulation of the Drosophila chromosome 4 by the histone H3K9 methyltransferase dSETDB1. Proc Natl Acad Sci U S A (2007) 1.17
Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem (2011) 1.10
DNA methyltransferase gene dDnmt2 and longevity of Drosophila. J Biol Chem (2004) 1.10
The eukaryotic DNMT2 genes encode a new class of cytosine-5 DNA methyltransferases. J Biol Chem (2003) 1.09
Substitution rate and structural divergence of 5'UTR evolution: comparative analysis between human and cynomolgus monkey cDNAs. Mol Biol Evol (2005) 0.97
Neuronal function and dysfunction of Drosophila dTDP. PLoS One (2011) 0.96
Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus. Mol Cell Biol (2005) 0.93
Ankrd17, an ubiquitously expressed ankyrin factor, is essential for the vascular integrity during embryogenesis. FEBS Lett (2009) 0.89
The NeuARt II system: a viewing tool for neuroanatomical data based on published neuroanatomical atlases. BMC Bioinformatics (2006) 0.87
IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice. Neurobiol Dis (2011) 0.86
Tools for knowledge acquisition within the NeuroScholar system and their application to anatomical tract-tracing data. J Biomed Discov Collab (2006) 0.86
Erythroid gene suppression by NF-kappa B. J Biol Chem (2003) 0.86
Developmental silencing of human zeta-globin gene expression is mediated by the transcriptional repressor RREB1. J Biol Chem (2010) 0.85
TDP-43 regulates the mammalian spinogenesis through translational repression of Rac1. Acta Neuropathol (2012) 0.84
Actin-based modeling of a transcriptionally competent nuclear substructure induced by transcription inhibition. Exp Cell Res (2006) 0.82
Eukaryotic methyl-CpG-binding domain proteins and chromatin modification. Eukaryot Cell (2003) 0.81
NeuroScholar's electronic laboratory notebook and its application to neuroendocrinology. Neuroinformatics (2006) 0.81
Angiopoietin-like protein 1 expression is related to intermuscular connective tissue and cartilage development. Dev Dyn (2007) 0.79
The dengue virus envelope protein induced PAI-1 gene expression via MEK/ERK pathways. Thromb Haemost (2010) 0.79
Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions. J Biomed Sci (2013) 0.78
Misregulated progesterone secretion and impaired pregnancy in Cyp11a1 transgenic mice. Biol Reprod (2013) 0.77
Relationship between trapezius muscle activity and typing speed: taping effect. Ergonomics (2012) 0.77